Search Results

• • 58 

    Academic Journals

  • Sort by: sorttype.publication.date.desc Newest sorttype.publication.date.asc Oldest sorttype.relevance Relevance

• Herpes vaccine fail

  From:Nature (Vol. 467, Issue 7316) Peer-Reviewed

  Oct. 7, 201064 words Brief article 1200LAn experimental vaccine against herpes simplex virus (HSV) failed to prevent infection in a trial of more than 8,000 women, its manufacturer GlaxoSmithKline announced last week. The drug firm, based in London, plans to...

• Despite barriers, FPs are likely to advise Herpes Zoster vaccine for older patients

  Author:Miriam E. TuckerFrom:Family Practice News (Vol. 36, Issue 7)

  Apr. 1, 2006551 words Article 2710LATLANTA -- Most family physicians and internists would recommend the herpes zoster vaccine to their older patients despite concerns about the vaccine's cost and reimbursement for its administration, Dr. Allison Kempe...

• Bulletin Board

  From:Future Microbiology (Vol. 5, Issue 12)

  Dec. 20101,583 words Article 1510LReport suggests that the number of deaths caused by malaria in India is much higher than WHO reports suggest New study claims that the current method of estimating malaria deaths is flawed. A study funded by the...

• Live attenuated varicella vaccine

  Authors:Ann M. Arvin and Anne A. GershonFrom:Annual Review of Microbiology (Vol. 50) Peer-Reviewed

  Annual 199619,508 words Article Varicella, more commonly known as chicken pox, is an annual epidemic common in temperate climates and usually infects children between the age of five and 10. Herpes zoster is a disease caused by the reactivation of a...

• Vaccine protects older people against herpes zoster

  From:Nursing Standard (Vol. 25, Issue 35) Peer-Reviewed

  May 4, 2011224 words Brief article 1270LGiving older people a herpes zoster vaccination reduces the incidence of shingles. About a million episodes of herpes zoster occur annually in the United States. Although pre-licence data provide evidence that the...

• Varicella zoster virus vaccine potentially cost effective in Canada.

  From:PharmacoEconomics and Outcomes News (Vol. 593)

  Dec. 1, 2009231 words Brief article 1260LThe live varicella zoster virus vaccine may be cost effective in British Columbia, Canada, according to research published in Pharmacoeconomics. Researchers constructed a discrete-event simulation model to calculate...

• Development of prophylactic vaccines for genital and neonatal herpes

  Authors:Cheryl A. Jones and Anthony L. CunninghamFrom:Expert Review of Vaccines (Vol. 2, Issue 4) Peer-Reviewed

  Aug. 1, 20035,750 words Report Over five decades numerous conventional candidate live attenuated and killed vaccines have failed to prevent genital herpes in clinical trials. However, a vaccine consisting of recombinant glycoprotein D from herpes...

• News in brief

  From:Expert Review of Vaccines (Vol. 12, Issue 4) Peer-Reviewed

  Apr. 2013758 words Report 1430LResults from the Shingles Prevention Study (SPS) have recently called into question the response to the shingles vaccine in untreated patients suffering from depression. The depression substudy of the SPS sought to...

• Is the varicella-zoster vaccine too costly?

  Author:Jonathan D. BeckFrom:Patient Care for the Nurse PractitionerPeer-Reviewed

  Nov. 2006184 words Brief article 1620LHornberger J, Robertus K. Cost-effectiveness of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. Ann Int Med. 2006;145:317-325. Vaccinating adults aged 60 and older with varicella-zoster...

• What you need to know about herpes zoster vaccination: recommendations from the CDC

  From:Consultant (Vol. 48, Issue 7) Peer-Reviewed

  July 20081,012 words Clinical report 1580LThe CDC's Advisory Committee on Immunization Practices (ACIP) recommends that all persons older than 60 years be immunized against herpes zoster with a single dose of the live, attenuated virus vaccine. Furthermore, it...

• Vaccine Seems to Prevent Genital Herpes in Women

  Author:MIRIAM E. TUCKERFrom:Family Practice News (Vol. 30, Issue 21)

  Nov. 1, 2000585 words Brief article HSV-negative preteen girls are likely target. TORONTO -- The first vaccine to show efficacy in preventing genital herpes disease has two small problems: It only works in women and only in those who are seronegative...

• Awareness and Attitude of Family Physicians About Human Papilloma Virus and Herpes Zoster Vaccines/Aile Hekimlerinin Insan Papilloma Virusu ve Zona Asilari Hakkindaki Bilgi Duzeyleri ve Tutumlarinin Arastirilmasi

  Authors:Rukiye Aysu Revanli, Ceren Yuceer, Esin Senol, Alpay Azap, Ayse Erbay, Sema Alp- Cavus, et al.From:KLIMIK Journal (Vol. 29, Issue 1) Peer-Reviewed

  Apr. 20164,052 words Report 1350LObjective: In this study, it is aimed to examine knowledge and attitudes about HPV and herpes zoster vaccines among family physicians. Methods: The study was conducted at 5th Annual International Family Practice...

• Why is zoster vaccine needed after shingles?

  Author:Khiem T. TranFrom:ConsultantPeer-Reviewed

  Feb. 2010316 words Brief article, Repor... 1290LA documented anti-varicella-zoster virus (VZV) titer is generally accepted as evidence of protection against VZV infection, and a known case of shingles, such as that described in the Photoclinic case of an older man...

• Herpes vaccine

  From:Nature Medicine (Vol. 16, Issue 11) Peer-Reviewed

  Nov. 201036 words Brief article 1760LSept 30 GlaxoSmithKline said it had halted development of its herpes vaccine for women, Simplirix, after the US National Institutes of Health (NIH) reported the vaccine failed to protect against genital herpes in an...

• Zostavax elicits antibody response in younger group

  Author:Miriam E. TuckerFrom:Family Practice News (Vol. 37, Issue 11)

  June 1, 2007496 words Article 1510LBALTIMORE -- The herpes zoster vaccine is as immunogenic in adults aged 5059 as it is in those aged 60 and older, Santosh C. Sutradhar, Ph.D., reported at a conference on vaccine research sponsored by the National...

• Herpes Zoster Vaccine: Is It Known?/Zona Asisi: Taniniyor mu?

  Author:Haluk EraksoyFrom:KLIMIK Journal (Vol. 29, Issue 1) Peer-Reviewed

  Apr. 2016586 words Editorial 1480LVarisella-zoster virusu (VZV), cocukluk caginda edinildiginde nispeten hafif bir hastalik olan sucicegine neden olur. Virus, bir kez infeksiyon olusturduktan sonra sinir gangliyonlarinda latent olarak kalir; daha cok...

• Genital herpes vaccine protects subset of women. (Women Who are HSV-1 and -2 Seronegative)

  Author:Kathryn DeMottFrom:Family Practice News (Vol. 32, Issue 7)

  Apr. 1, 2002560 words Article NEW ORLEANS -- An investigational vaccine appears to provide significant protection against symptomatic genital herpes in select women, Dr. Kimberly Yeung-Yue said at the annual meeting of the American Academy of...

• Stop shingles in its tracks: herpes zoster and its sequelae are painful, debilitating--and largely preventable. So why isn't vaccination more widespread?

  Authors:Pierre-Olivier Lang, Yasmine Hasso, and Jean Pierre MichelFrom:Journal of Family Practice (Vol. 58, Issue 10) Peer-Reviewed

  Oct. 20092,229 words Article PRACTICE RECOMMENDATIONS * Initiate antiviral treatment as soon as possible; rapid resolution of acute pain and reduction in the development of postherpetic neuralgia (PHN) are most likely when therapy is started...

• Zostavax

  From:Formulary (Vol. 46, Issue 4) Peer-Reviewed

  Apr. 201125 words Brief article 1540LAn expanded age indication for Zoster Vaccine Live (Zostavax, Merck) was approved for the prevention of herpes zoster in adults aged 50 to 59 years....

• Developing an asymptomatic mucosal herpes vaccine: the present and the future

  Authors:Gargi Dasgupta, Anthony B Nesburn, Steven L Wechsler, and Lbachir BenMohamedFrom:Future Microbiology (Vol. 5, Issue 1)

  Jan. 20102,479 words Report 1470LAuthor(s): Gargi Dasgupta 1 , Anthony B Nesburn 2 , Steven L Wechsler 3 , Lbachir BenMohamed [[dagger]] 4 The development of prophylactic and therapeutic vaccines against infectious diseases has been a great success...